Skip to content

Public FDA record

Z-2425-2021: Atellica IM BR 27.29 (BR) Assay 250 Test Kit- in vitro diagnostic use in the quantitative serial determin

Recall record Z-2425-2021 for Siemens Healthcare Diagnostics, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2425-2021
Company in FDA record
Siemens Healthcare Diagnostics, Inc
FDA record creation date
Sep 3, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Product does not meet the Instructions for Use (IFU) claimed Pack Calibration Interval of 10 days. IFU calibration updated interval from 10 days to 3 days for all current and future kit lot numbers

Source facts

Action
Siemens Healthcare issued Urgent Medical Device Correction (UMDC) via FedEx beginning on 07/06/2021. An Urgent Field Safety Notice (UFSN) was issued to all OUS Siemens sites with affected customers electronically for distribution and regional reporting to their local competent authorities beginning on 07/06/2021. Letter states reason for recall, health risk and action to take: Please review this letter with your Medical Director. Change the BR assay Pack Calibration Interval on each Atellica IM analyzer from 10 days to 3 days. See Additional Information for instructions on changing the Pack Calibration Interval. All Atellica IM BR assay kit lots can continue to be utilized with the updated Pack Calibration Interval of 3 days. Continue to follow the Atellica IM BR IFU claimed 28-day On-board Stability and 32-day Lot Calibration Intervals. Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. If you have received any complaints of illness or adverse events associated with the products listed in Table 1, immediately contact your local Siemens Healthineers Customer Care Center or your local Siemens Healthineers technical support representative. Please retain this letter with your laboratory records and forward this letter to those who may have received this product. If you have any questions, please contact your Siemens Healthineers Customer Care Center or your local Siemens Healthineers technical support representative. Additional Information Instructions for Changing the Pack Calibration Interval on Atellica IM Analyzers Instructions for updating the BR Pack Calibration Interval from 10 days to 3 days on each Atellica IM analyzer are outlined below. 1) Sign into Atellica IM analyzer as Labmanager user level 2) In the Worklist Overview screen, move all BR results to Historical 3) In the Setup screen, select Test Definition, select IM Test Definition, and select BR Test 4) Select the Calibration Tab 5) Under Pack C
Initiated
2021-07-06
Root cause
Under Investigation by firm
Distribution
Worldwide distribution. US Nationwide, Australia, Bahamas, India, Mexico, Saudi Arabia, and Viet Nam
Recall number
Z-2425-2021
Recall status
Open, Classified
CDRH record ID
188627
FDA record created
2021-09-03
Recall event number
88431

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗